ReviewJournal of pediatric gastroenterology and nutrition2026
Current status in paediatric liver transplantation for inherited metabolic diseases.
Review in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Liver transplantation (LT) has evolved over the past few decades and is now an established therapy for several inherited metabolic diseases (IMDs) with overall good long-term outcomes. IMDs are now the second most common indication for paediatric LT with increasing waiting times and expanding indications. There have been innovations in surgical techniques and graft viability over the years to increase the donor pool. This group of patients poses several challenges including the increasing complexity of diseases considered amenable to LT, survival into adulthood, metabolic and neurocognitive monitoring post-LT. Following an international meeting of experts, we present a summary of current views and trends in paediatric LT for IMDs. We highlight that LT continues to offer a realistic alternative therapeutic approach despite the potential advancement in novel therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.